Introduction: The Frontier of Drug Discovery in GI, Metabolic, and Autoimmune Disorders The landscape of gastroenterology, metabolic health, and autoimmunity is undergoing a seismic shift. For researchers and procurement specialists, understanding the bridge between preclinical mechanisms and clinical application is vital. Drugs like Mesalamine and Budesonide have long been the standard for inflammatory bowel conditions, while next-generation biologics like Stelara and metabolic modulators […]

